Squarepoint’s Zymergen Inc. Common Stock ZY Stock Holding History

Squarepoint’s Portfolio ZY Stock Details ZY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-12,166	Closed	-$81K	–	3817
2021 Q4	$81K	Buy	+12,166	New	+$118K	﹤0.01%	2961

Other funds holding ZY

SIAU

SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

TVPI

True Venture Partners IV Palo Alto, California $8.41M AUM 78.89% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DCI

Data Collective II Palo Alto, California $8.44M AUM 11.7% 1-Year Est. Return

TSV

Two Sigma Ventures New York $9.61M AUM 58.41% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Squarepoint's ZY Position: Q1 2022 in Review

Squarepoint sold out of Zymergen Inc. Common Stock (ZY) in Q1 2022, closing a stake of 12,166 shares — an estimated $81K sold.

Squarepoint first reported a position in ZY in Q4 2021 and held it in 1 quarter. The position peaked at $81K in Q4 2021. 91 funds tracked by Wall St. Rank hold ZY as of Q1 2022.

Squarepoint reported no remaining Zymergen Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
Squarepoint sold 12,166 Zymergen Inc. Common Stock shares in Q1 2022, an estimated $81K.
Squarepoint first reported a position in Zymergen Inc. Common Stock in Q4 2021 and held it in 1 quarter.
Squarepoint's Zymergen Inc. Common Stock position peaked at $81K in Q4 2021.
91 funds tracked by Wall St. Rank held Zymergen Inc. Common Stock as of Q1 2022.

Based on Squarepoint's 13F filing for Q1 2022, filed 16 May 2022.